Le Terrier C, Bouvier M, Kerbol A, Dell'Acqua C, et al. In-vitro activity of the novel beta-lactam/beta-lactamase inhibitor combinations and
cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates
collected in Switzerland in 2022. Eur J Clin Microbiol Infect Dis 2025;44:571-585.
PMID: 39704920
|